Our lawyers are investigating Ozempic lawsuits for patients with gallbladder disease or gastrointestinal conditions, including gastroparesis or cyclic vomiting syndrome.
Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type-2 diabetes. Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gallstones and gallbladder disease, which frequently results in surgical removal of the gallbladder.
Until recently, the warning label for Ozempic did not correctly notify patients or doctors about the risk of gallbladder disease. Anyone who suffered gallbladder disease or gallstones after taking Ozempic may be able to get financial compensation for their injuries by filing a product liability lawsuit. There are now lawsuits involving Ozempic, Rybelsus, Wegovy, Trulicity, and Mounjaro that, as of February 2024, is an MDL class action lawsuit.